Sarepta Therapeutics (SRPT) Q4 2020 Earnings Call Transcript msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Operator
Good evening, and welcome to Oyster Point Pharma s fourth-quarter 2020 earnings conference call. My name is Josh, and I will be your operator today. [Operator instructions] At this time, I would like to turn the call over to Mr. Daniel Lochner, Oyster Point Pharma s chief financial officer.
Sir, please go ahead.
Chief Financial Officer
Good evening, everyone, and welcome to the Oyster Point Pharma fourth-quarter earnings conference call for the three months ending December 31, 2020. This evening, we issued a press release containing our fourth-quarter financial results and recent business highlights. In addition, our earnings press release and our Form 10-K that we filed with the SEC this evening are available on our website under the Investor and News section at www.oysterpointrx.com. Joining us on our call today are Dr.